Holen Sie sich die Stockscreener-App
22.61
3.17%
-0.74
Handel nachbörslich:
22.58
-0.03
-0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Baxter International stock trades steady as spin-off of kidney care business and margin focus shape - ad-hoc-news.de
Baxter Stock: The Chart Points Higher, Valuation & Growth Are Less Appealing (NYSE:BAX) - Seeking Alpha
Baxter International Appoints Michael Lemberger as Director of People Analytics - hrtoday.in
Baxter International stock trades steadily as spin-off and portfolio reshaping reshape earnings prof - ad-hoc-news.de
Baxter International (BAX) Q4 2024 earnings summary - Quartr
Is Baxter International Inc (BAX) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter stock trades steady as spin-off and earnings reshape the profile - ad-hoc-news.de
Baxter International's Q2 2026 earnings: What to expect - MSN
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter stock holds steady as restructuring and spin-off reshape the portfolio - ad-hoc-news.de
Is Baxter’s Class I Respiratory Device Recall Reshaping the Investment Case for Baxter International (BAX)? - Sahm
Baxter International Updates Segment Reporting Structure and Metrics - The Globe and Mail
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - Stock Traders Daily
Baxter International (BAX) Announces Recast of Financial Reporti - GuruFocus
A Look at Baxter International Inc (BAX) After 3.4% Decline -- G - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter reorganizes to two segments, recasts prior-period segment results and discloses operational/organic sales metrics - TradingView
Baxter (NYSE: BAX) recasts 2025 segment sales and shows $505M loss - Stock Titan
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating - Moomoo
ETFs Investing in Baxter International Inc. Stocks - TradingView
Baxter stock reflects a diversified medical technology business - ad-hoc-news.de
Baxter International stock reflects a diversified medical portfolio and ongoing portfolio transforma - ad-hoc-news.de
Baxter International Inc. (BAX) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors - Business Wire
Retia Medical Adds Former Baxter Executive Christopher Benassi to Advisory Board - citybiz
Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Citi Sticks to Its Sell Rating for Baxter International (BAX) - The Globe and Mail
Baxter Beats Stable Value Fund 401(k) Plan Suit, For Good - Law360
A Look at Baxter International Inc (BAX) After 3.9% Decline -- G - GuruFocus
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter International balances portfolio focus and steady operations - Ad Hoc News
Baxter International focuses on core medical technologies as investors watch US healthcare demand - ad-hoc-news.de
Baxter International Again Defeats 401(k) Stable Value Fund Suit - Bloomberg Law News
Baxter International (BAX) Is Up 7.2% After Dual Russell 2500 Index AdditionsWhat's Changed - simplywall.st
Baxter International's Q2 2026 Earnings: What to Expect - inkl
The Sigma Spectrum Infusion SystemBaxter International targets smarter IV safety - ad-hoc-news.de
Baxter International focuses on core healthcare business as investors watch its portfolio moves - ad-hoc-news.de
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions? - Yahoo Finance
Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative? - Yahoo Finance
Baxter International balances medical technology breadth with long-term investment themes - ad-hoc-news.de
Why Is Baxter (NYSE:BAX) Featured Across Major US Indices? - Kalkine Media
Baxter International focuses on core portfolio as investors weigh long-term growth prospects - ad-hoc-news.de
Evercore ISI Adjusts Price Target on Baxter International to $24 From $22 - Moomoo
Baxter International focuses on medical products as investors watch long-term strategy - ad-hoc-news.de
The Spectrum IQ Infusion System from Baxter Internationalsmart pumps push safer drug delivery - AD HOC NEWS
Baxter International focuses on medical products and patient care - AD HOC NEWS
The PrisMax SystemBaxter International extends care for chronic kidney patients - AD HOC NEWS
Baxter International Inc. Actuals & Estimates (SWB:BTL) - TradingView
Baxter International outlines its healthcare strategy as investors watch the stock - AD HOC NEWS
BAX News | BAXTER INTERNATIONAL INC (NYSE:BAX) - ChartMill
Baxter International Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Baxter International stock on the company backdrop. Trading stays tied to the wider health care setu - AD HOC NEWS
Evercore ISI Group Lowers Price Target for Baxter International (BAX) to $22 | BAX Stock News - GuruFocus
Baxter International outlines its healthcare focus as investors watch the stock - AD HOC NEWS
The Exacta HD dialyzerBaxter International targets high-flux performance for US dialysis centers - AD HOC NEWS
List of 21 Acquisitions by Baxter (Jul 2026) - Tracxn
Global Human Fibrinogen Concentrate Market Size/Share Worth USD 2.78 Billion by 2035 at a 11.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
A Look at Baxter International Inc (BAX) After 3.2% Decline -- G - GuruFocus
BAX Investors Have Opportunity to Lead Baxter International, Inc - The National Law Review
Baxter International consensus picture on Wall Street, shares trade steadily on NYSE - AD HOC NEWS
Is Baxter International stock underperforming the S&P 500? - MSN
Lazard Equity Franchise Portfolio's Baxter International Inc(BAX) Holding History - GuruFocus
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):